A public housing mould intervention programme in New York City has been shown to reduce asthma-related hospital A&E visits.
The New York City Housing Authority developed Mold Busters, a mould-removal programme, in response to a 2013 class-action lawsuit filed by residents suffering from asthma due to mould in their apartments.
New research presented at the ATS 2026 International Conference shows that the programme results in nearly 2,800 fewer asthma-related emergency department (ED) visits annually.
Researchers estimated that without the programme, New York City public housing residents would have experienced 25% more asthma-related ED visits.
This is the first large-scale observational study to show that citywide mould intervention projects can significantly reduce the burden of asthma exacerbations.
First author Nina Flores, PhD, who conducted this work while a doctoral student at Columbia University and is now a postdoctoral fellow at The University of Texas at Austin School of Social Work and Dell Medical School, said: “These results suggest that housing interventions on asthma triggers could play a critical role in reducing long-standing asthma disparities.”
Evidence-based
Mold Busters is a mould removal and remediation programme that improved mould-related response timelines, trained staff in evidence-based mould removal and led to large-scale improvements in ventilation in New York City public housing.
While smaller studies have suggested that these improvements can reduce asthma-related illnesses, researchers wanted to know whether these effects would be observed on a larger scale.
For the new study, the researchers compared ED visits for people living in New York City public housing with a control group of people living in nearby areas that had similar income levels.
The study found that public housing residents served by Mold Busters averaged nine fewer asthma-related ED visits per thousand people compared to residents in similar non-public housing areas, providing concrete evidence of the programme’s effectiveness.
Flores noted that buildings with the largest drops in mould complaints after having mould removal also saw the steepest declines in asthma-related emergency department visits.
This further supports the connection between Mold Busters’ intervention and observed health improvements.
While the research team measured ED visits, Flores said that the study did not capture the impacts of less-severe asthma exacerbations that might cause someone to miss work or school, as well as other allergic and respiratory problems that are associated with mould exposure.
She said: “The health benefits reported here likely underestimate the full scope of health-related benefits from the intervention.”
Researchers plan to repeat their analysis as other data becomes available, hoping to understand if benefits are sustained or even increase over time.
Mould removal and remediation may not just reduce exacerbations – it could prevent new asthma cases from developing, they said.
The team is also conducting home visits to collect data on fungal exposure, allergic sensitisation, and asthma-related illnesses among children in New York City public housing, both after a mould complaint and in the 12 months after mould removal.
